Related Experiment Video
Updated: Feb 16, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.
Dipak Kotecha1, Günter Breithardt2,3, A John Camm4
1Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
New strategies are needed to manage the growing population with atrial fibrillation (AF). This consensus conference explored innovative solutions for screening, diagnosis, and integrated care to improve patient outcomes and stroke prevention.
Area of Science:
- Cardiology
- Electrophysiology
- Public Health
Background:
- Atrial fibrillation (AF) patient populations are expanding, yet current therapies, excluding anticoagulation, show limited impact on mortality and adverse cardiovascular events.
- Existing AF management strategies require enhancement to address the increasing burden of the condition and improve patient prognoses.
Framework:
- The 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and European Heart Rhythm Association (EHRA) convened global specialists and industry partners.
- The conference focused on developing innovative solutions for AF management, emphasizing new approaches to screening, diagnosis, and integrated care.
Implementation:
- Exploration of novel technologies for enhanced clinical phenotyping and personalized treatment selection.
- Development of structured, integrated care models and clinical pathways for complex AF patients.
- Improvement of stroke prevention strategies and patient selection for rate and rhythm control therapies.
Implications:
- The proposed innovative approaches have the potential to significantly improve patient outcomes in atrial fibrillation.
- Enhanced phenotyping, stratified therapy, and integrated care pathways are crucial for advancing AF management.
- This consensus provides a roadmap for future research and clinical practice in atrial fibrillation treatment.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Integration by Parts: Indefinite Integrals
Integration by Parts: Definite Integrals
Tonsillitis II: Management

